Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 14Breast Neoplasms 11Prostatic Neoplasms 9Obesity 7Insulin Resistance 6Carcinoma, Non-Small-Cell Lung 5Lung Neoplasms 4Colorectal Neoplasms 4Motor Activity 3Adenocarcinoma of Lung 3Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Neoplasms 2Menstruation Disturbances 2Lymphoma, Large B-Cell, Diffuse 2Head and Neck Neoplasms 2Endometrial Neoplasms 2Diabetes Mellitus 2Weight Loss 1Urothelial Cancer 1Thyroid Diseases 1Thoracic Neoplasms 1Smoldering Multiple Myeloma 1Rectal Neoplasms 1Prediabetic State 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Effusion, Malignant 1Overweight 1Ovarian, Fallopian Tube, and Primary Peritoneal Cancer 1Non-alcoholic Fatty Liver Disease 1

Interventions

Medroxyprogesterone Acetate 2Clomiphene 2salicylsalicylic acid 1Sodium Salicylate 1Raloxifene Hydrochloride 1Progestins 1Nimodipine 1Metformin 1Glycoprotein Hormones, alpha Subunit 1Flutamide 1Chorionic Gonadotropin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Anovulation × Metformin × Clear all
NCT00151411 2018-03-21

Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS)

Milton S. Hershey Medical Center

Phase 2 Completed
114 enrolled 10 charts

Anovulation, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡